Due to the end of negative interest rates, well-capitalised companies in the canton of Zurich will be able to claim the deduction for excess equity for the first time in 2023. The additional R&D deduction is not just for start-ups or pharmaceutical companies, but can also be very interesting for SMEs in particular.

If the election of the Board of Directors is not carried out on time, this may result in a lack of governing bodies. This may result in all subsequent resolutions of a general meeting of shareholders being deemed null and void.

With a record number of bankruptcy proceedings in Switzerland in 2023, efficient debt management is more crucial than ever to help companies in financial distress get back on track and ensure long-term stability.